Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02941692
Other study ID # 31736
Secondary ID K12HD055885
Status Completed
Phase Phase 2
First received
Last updated
Start date June 2014
Est. completion date March 2017

Study information

Verified date September 2018
Source Medical University of South Carolina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Oxytocin is a promising new medication found to have positive effects on prosocial behavior, reduce negative affect such as fear and anxiety, and reduce stress-induced addictive behaviors. This study aims to investigate the extent to which a 40 IU dose of intranasal oxytocin improves couples' conflict resolution skills and subjective, physiological, and neuroendocrine responses to conflict. Conflict resolution discussions will take place in the laboratory and will be videotaped.


Description:

Substance use disorders (SUD) are characterized by dysregulation of the hypothalamic-pituitary axis (HPA). The neuropeptide oxytocin, commonly administered as an intranasal spray, is a drug that has prominent anxiolytic and prosocial effects on human behaviors. While the mechanisms of action facilitating the behavioral effects of oxytocin in humans is complex and many questions about this process remain, there is a consensus in the existing literature that oxytocin modulates HPA axis reactivity to stressful social stimuli. Preliminary studies suggest that oxytocin is known to reduce couple conflict among normative couples. A more developed line of research indicates that oxytocin mitigates addictive behaviors in the context of various drugs of abuse. Given the high prevalence and severity of dyadic conflict among couples where one or both partner has substance abuse, and given the salience of dyadic conflict as a precipitant to substance use behaviors, it is critical to investigate the therapeutic effects of oxytocin among couples with substance use problems. Namely, oxytocin holds promise as a potential augmenter for conjoint couples therapies, particularly those targeting the reduction of substance use problems. However, only two studies have examined the effects of oxytocin on couples' communication behaviors. Those two studies found that couples' communication skills improved following the administration of oxytocin. It is important to extend this line of research to examine conflict resolution skills among couples with substance use problems. To date, no studies have examined the effects of oxytocin on subjective, physiological, or neuroendocrine reactivity to dyadic conflict. The present study aims to fill that gap in the literature.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

1. 18-65 years of age

2. both partners are willing to participate, and

3. at least one partner has engaged in hazardous drinking (i.e. 4 or more drinks for women, 6 or more for men) or illicit drug use during the past 60 days

Exclusion Criteria:

1. pregnancy for women

2. current psychotic or bipolar disorders

3. active suicidal or homicidal ideation and intent

4. subjects who would present a serious suicide risk, such as those with severe depression, or who are likely to require hospitalization during the course of the study

5. severe, unilateral intimate partner violence in the past year

6. BMI greater than 39.

Study Design


Intervention

Drug:
Oxytocin

Placebo
Placebo for Oxytocin

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Medical University of South Carolina Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Frequency of Distress Maintaining Attributions Couples' conflict resolution discussions are video recorded and coded according to an observational coding system: the Rapid Marital Interaction Coding System, which assesses the frequency of behaviors (distress maintaining attributions and relationship enhancing attributions) during the 10 minute conflict resolution discussion. This variable is operationalized as the number of instances of distress maintaining attributions during each of two ten minute conflict resolution discussions. Frequency of distress maintaining attrbibutions per 10 minutes
Secondary Change in Salivary Cortisol (µg/dL) Cortisol samples are collected at baseline, pre-post each conflict resolution discussion, and at 15, 30, and 60 minute post-task intervals. Measured at 7 time points: Baseline, immediately before and after Conflict Resolution Task #1, Immediately after Conflict Resolution Task #2, and at 15, 30, and 60 minutes following the completion of Conflict Resolution task #2.
See also
  Status Clinical Trial Phase
Recruiting NCT05736211 - Organization-level Youth Engagement Approach for Substance Misuse Prevention N/A
Completed NCT05517382 - A Digital Game Targeting Suicide Prevention in Adolescents Who Report Substance Misuse N/A